Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
Expression of Interest for innovative and rapid health-related approaches to respond to COVID-19 and to deliver quick results for society for a higher level of preparedness of health systems.
Característiques principals
Topics:
  • SC1-PHE-CORONAVIRUS-2020-2A - Repurposing of manufacturing for vital medical supplies and equipment
    https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/sc1-phe-coronavirus-2020-2a
  • SC1-PHE-CORONAVIRUS-2020-2B - Medical technologies, Digital tools and Artificial Intelligence (AI) analytics to improve surveillance and care at high Technology Readiness Levels (TRL)
    https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/sc1-phe-coronavirus-2020-2b
  • SC1-PHE-CORONAVIRUS-2020-2C - Behavioural, social and economic impacts of the outbreak response
    https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/sc1-phe-coronavirus-2020-2c
  • SC1-PHE-CORONAVIRUS-2020-2D - Pan-European COVID-19 cohorts
    https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/sc1-phe-coronavirus-2020-2d
  • SC1-PHE-CORONAVIRUS-2020-2E - Networking of existing EU and international cohorts of relevance to COVID-19
    https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/sc1-phe-coronavirus-2020-2e
    		•
    Lloc de presentació
    El personal de l'IMIM i el PSMAR que necessiteu més informació adreceu-vos a:
    Servei de Recerca. C/Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.04.00.
    - Carol Barnwell, cbarnwell@imim.es, Ext.: 1670
    - Marta López, mlopez4@imim.es, Ext: 1576
    Requisits
    International consortia formed by at least three legal entities. Each of the three must be established in a different EU Member State or Horizon 2020 associated country. For topic SC1-PHE-CORONAVIRUS-2020-2E, at least one legal entity established in an EU Member State or Horizon 2020 associated country.
    Dotació
  • SC1-PHE-CORONAVIRUS-2020-2A:EUR 5-6 million
  • SC1-PHE-CORONAVIRUS-2020-2B: EUR 2-5 million
  • SC1-PHE-CORONAVIRUS-2020-2C: EUR 4-10 million
  • SC1-PHE-CORONAVIRUS-2020-2D: EUR 15-20 million
  • SC1-PHE-CORONAVIRUS-2020-2E: EUR 2-3 million
    • Durada
    3-24 months
    AVÍS IMPORTANT
    Restrictions on applications will apply to the 2020 calls based on the outcome of the evaluation of previous calls – see restrictions on submission of proposals under the “Eligibility criteria” section in the Work Programme.

    Restrictions on applications will also apply to Principal Investigators whose proposals have been rejected on grounds of breach of research integrity.

    Beneficiaries of ERC frontier research grants funded under this Work Programme will automatically be covered by the provisions on research data sharing unless they specifically decide to opt-out – see section on open access under “Objectives and Principles of ERC Funding” in the Work Programme.

    Arxius

    Arxiu